Immune checkpoint inhibitors are among the most successful treatments developed for advanced cases. These drugs work by removing the brakes on immune cells, allowing them to attack cancer. The most ...

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

Researchers found that combining trametinib, rigosertib, and a CD40 agonist blocked immune-suppressive B cells and restored ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...

For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...

Akeso, Inc. (9926.HK) ("Akeso"), and INOVIO (NASDAQ: INO) today announced that they have entered into a clinical trial collaboration and supply agreement to evaluate cadonilimab, Akeso's ...

Locoregional therapy for hepatocellular carcinoma before transplant: Impact on tumor necrosis, tumor recurrence, and long-term survival. This is an ASCO Meeting Abstract from the 2026 ASCO ...

In addition, the study will evaluate tolododekin alfa in combination with standard of care immune checkpoint blockade in first-line treatment of patients with metastatic, non-mutated NSCLC and a tumor ...

A new study from Moffitt Cancer Center brings fresh hope to patients battling advanced melanoma who aren’t helped by today’s best treatments. Researchers have found a powerful combination of three ...